Neonatal sepsis: epidemiology and management

Area of Science:

• Neonatal Medicine
• Infectious Diseases
• Pharmacology

Background:

• Neonatal sepsis incidence is low but rises with prematurity and maternal complications.
• Nosocomial infections are increasing, particularly in infants hospitalized long-term in neonatal intensive care units (NICUs).
• Congenital malformations and surgical conditions contribute to NICU admissions and sepsis risk.

Purpose of the Study:

• To review the challenges and considerations in managing neonatal sepsis.
• To highlight the importance of appropriate antimicrobial therapy in neonates.
• To address the growing issue of antimicrobial resistance in NICUs.

Main Methods:

• Review of current literature and clinical practices regarding neonatal sepsis management.
• Analysis of factors influencing antimicrobial selection and dosing in neonates.
• Discussion of the impact of antimicrobial use on bacterial resistance patterns.

Main Results:

• Antimicrobial therapy is often initiated empirically based on likely pathogens.
• Limited safe antimicrobial options exist for neonates, requiring dose adjustments for weight and age.
• Indiscriminate use of broad-spectrum agents contributes to significant bacterial resistance in NICU flora.

Conclusions:

• Treatment decisions for neonatal sepsis require careful consideration of clinical presentation, laboratory data, and patient history.
• Judicious antimicrobial use is essential to preserve efficacy and combat rising resistance.
• Understanding neonatal pharmacokinetics and pharmacodynamics is critical for safe and effective treatment.